Research on iodine metabolism was reviewed with special reference to short-term processes, pregnancy, and lactation. A detailed discussion of the new physiologicallyoriented biokinetic model and a model parameterization procedure are given. Predictions of the new model are applicable for the analysis of in vivo and in vitro clinical data gained using iodine or radioactive tracers, as well as for the assessment of radiation exposure doses to mothers and offspring. The model can be used to simulate biokinetic processes in the human body, for prediction of biokinetic parameters such as the time course of thyroid uptake (both for mother and fetus), the rate of exertion with urine, and the level of iodine secretion with saliva and breastmilk. The structure of the model is applicable in a wide range of stable iodine in the diet, both for pregnant and non-pregnant persons.
Introduction
This paper continues the discussion of the model for the transfer of iodine to the fetus, which has been developed by the author [1, 2] for new publication of the International Commission on Radiological Protection (ICRP) [3] . The model includes a more complex representation of iodine biokinetics in the mother than used previously by ICRP [4] and others [5] [6] [7] .
Changes to the adult model were considered necessary to provide adequate estimates of tissue exposure from short half-life iodine isotopes and radiation doses to the embryo from iodine in non-thyroidal maternal tissues. The model takes account of available data on changes in iodine metabolism during pregnancy, uptake of iodine by the placenta, amniotic fluid and the fetus, and changes in fetal thyroid mass and iodine concentration. Due to the radiological destination of the discussed model the scope of this paper is restricted by deliberate neglect of the mechanism of hormone metabolism. The metabolism of synthetic iodine-containing compounds which are foreign to the body is also out of the scope of this paper.
Development of the models

Model of short-term biokinetic processes
The structure of the model is presented in figure 1 and parameter values estimated for the euthyroid adult are discussed below and summarized in table 1. The notation of model compartments is explained in figures 1 and 2.
Alimentary tract
Absorption
The absorption rate of ingested iodine from the gastrointestinal tract as a whole was estimated to be in the range 0.01 to 0.05 min -1 [8] . Ingested iodide (I -) is absorbed rapidly from the small intestine (compartment (SI) and more slowly from the stomach (St) [9] .
Gastroenteric cycle of iodide
The stomach and a portion of the small intestine have an active (against the gradient of concentrations) iodide transport from the serosal to the mucosal surface. The iodide appears in the stomach contents within 0.5 to 1 hour after the intramuscular injection of Na 131 I [8] . The concentration ratios of iodide in saliva and gastric juice relative to plasma are 30 to 50 [8] [9] [10] . In one ICRP publication 23 [11] concentrations of iodide in saliva and gastric juice are given as 3.5 to 24 µg dl -1 .
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88 juice (J) and its subsequent re-absorption represents the gastroenteric iodide cycle. Within three hours after ingestion, this cycle has been estimated to account for up to 23% of intake in humans; in dogs this value is about 20% to 30% [9, 12] . The daily secretions of saliva and gastric juice are 0.5 to 2 L and 2 to 2.5 L, respectively [11, 12] .
In the classical Riggs's review [6] both the delay in absorption and the delay in distribution are disregarded. Riggs assumed that the radioactive iodine is instantaneously and evenly distributed throughout the iodine compartment. At the same time, Riggs indicated that "This assumption is obviously not legitimate if much importance is to be attached to the fate of radioactive iodine during the first hour or two after administration." The model developed in this study has demonstrated that the iodine early kinetics is a most important process, which governs the dose estimation for short-lived radioiodines, such as 132 I, 133 I, and 135 I.
Waune [13] stated that iodine in saliva is entirely inorganic, even in pathological cases, when significant amounts of the organic iodine are present in the urine. Putz et al. [14] reported a value 1 nmol l -1 as a mean level of thyroxine (T 4 ) in saliva. There was a good correlation between the saliva and serum T 4 concentrations (r = 0.74) and between saliva T 4 values and the T 4 /(thyroxine-binding globulin) ratio (r = 0.83). a. The 1.7E+1 denotes 1.7 × 10 1 b. Non-zero for post-partum. Parameters are discussed in the section "Model for lactation" St, stomach; SI, small intestine; ULI, upper large intestine, I, iodine; D, iodide in other; g, iodide; G, organic iodide; S, salivary glands; J, gastric secretory cells; K, kidneys; UB, urinary bladder; LLI, lower large intestine; F, feces; U, urine; B, organic iodine; Br, breasts; M, milk; O, ovaries.
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Model parameterization
Values of 40 d -1 (about 3% min. -1 ) and 300 d -1 were adopted in the model for iodine absorption from St and SI, respectively. The value for absorption from the stomach was based on the results of Egoroff et al. [8] , and the value for intestinal absorption corresponds to the gut absorption coefficient f 1 = 0.98. The iodide flux with saliva and gastric juice can be estimated by equations ϕ S→St = C SJ K S = 63 µg d -1 , and ϕ J→St = C SJ K J = 180 µg d -1 where C SJ = 9 µg d -1 is the iodide concentration in saliva or gastric juice, K S = 0.7 l d -1 is the salivary gland clearance rate and K J = 2 l d -1 is the gastric secretory cells clearance rate. The (saliva or gastric juice iodide)/(plasma iodide) concentration ratio of N = 30 has been adopted for setting iodide transfer rates: λ I→S = K S N / V I = 3 d -1 , and λ I→J = K J N / V I ≈ 8.6 d -1 , where V l = 7 l is the volume of the compartment I (the discussion see below). Values λ S→St = K S / V S = 10 d -1 and λ J→St = K J / V J = 20 d -1 have been used in the model (V S = 70 ml and V J = 100 ml are adopted in the model volumes of the iodide pool in secretory glands). In equilibrium the compartment I for non-pregnant women with a daily iodine intake of 150 µg d -1 has 21 µg of iodide (see below). Calculated in such manner transfer rates provide the required iodide flux with saliva and gastric juice.
Urinary excretion of iodide
The most important route of iodide excretion is by filtration through the kidney into the urine. Renal iodide clearance is remarkably constant for non-pregnant euthyroidal persons over all ranges of plasma iodine considered. In the euthyroidal state it is mostly the inorganic iodine component that is excreted in urine. Organic compounds are present in the urine in thyrotoxicosis and dyshormonogenesis (dehaloginase deficiency) only [13] . Moskalev [12] proposed a standard daily excretion rate of 135 µg d -1 for reference adults with a body weight of 70 kg.
Model parameterization
Renal clearance of iodide was assumed to be 45 ml min -1 , resulting in transfer rates from blood to kidneys (K) 6.4 d -1 (λ I→K = K U /V I ). The rate of transfer from K to urinary bladder (UB) was set to 10 d -1 in order to maintain a kidney iodine concentration of 5 µg dl -1 . The rate of transfer from UB to urine (U) was taken to be 12 d -1 , corresponding to six voids per day [15] .
Uptake of iodide by non-thyroidal tissues
Model parameterization
In the model the total maternal iodide distribution space was assumed to be 25 L [7, 16, 17], with 7 L cor- 
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New iodine models family 90 responding to iodide in blood and 18 L corresponding to tissues other than the thyroid. The homogenization in blood (compartment I) is taken to be more rapid than diffusion towards the tissue compartment (D). Brownell [18] estimated a rate of exchange between I and D of 14 l h -1 and, accordingly, using the volumes of compartments I and D, transfer rates were calculated as 48 d -1 for I to D and 19 d -1 for D to I. For an iodine intake of 150 µg d -1 , the model predicts the contents of compartment I and D at equilibrium as Q I = 21 µg and Q D = 57 µg of iodide, corresponding to reported concentrations of about 0.3 µgdl -1 [8, 10, 13] .
Ovaries
In the model, uptake of iodide by the ovaries is treated separately from uptake in other non-thyroidal tissues.
There is some evidence that iodine is concentrated in the ovary, particularly during the phase of follicular development [9] . Laginskaya et al. [19] reported peak radioiodine uptake by ovaries of rats in the range 0.3% to 5%. Iodide uptake of 1% and clearance with a half-time of 1 hour have been adopted (uptake rate of 17 d -1 ) for ovaries compartment.
Uptake of iodide by the thyroid and hormonal circulation
Thyroid
In contrast to renal clearance, thyroid clearance is sensitive to changes in the plasma concentration of iodide and varies greatly with the functional activity of the gland. In normal individuals, thyroid clearance averages 10 to 20 ml min -1 , while in cases of exophthalmic goiter, a clearance of over 100 ml min -1 and even over 1,000 ml min -1 is possible [8] . According to Aboul-Khair et al. [20] , iodide uptake by the gland in the control group (non-pregnant women) is 42 µg d -1 .
The organic iodine space in compartment G contains 8,000 µg of iodine [17] . Iodide is accumulated rapidly by the thyroid gland. Oxidation of iodide is a highly efficient process such that the concentration of Iin the gland is about 0.3% to 0.4% of the concentration of organically-bound iodine [12] . The model includes an iodide compartment in the thyroid (g) with 30 µg of stable iodine, that exchange with the organic iodine compartment (G) through the blood (I) and is included as a means of fitting data on the short-term uptake of Iby the thyroid. The model gives total uptake of 9% of iodine reaching blood after two hours and 25% after 24 hours, consistent with published data [21, 22] . The data of Mirkhodzhaev [22] are summarized in the table 2. The rates of transfer from I to G and I to g were taken to be equal and the rate from g to I fitted to correspond to the accumulation of 30 µg of stable iodide in g.
Model parameterization
The initial estimation of the thyroidal uptake rate was calculated by the equation λ I→G = K U S I /InV I , where K U is renal clearance. S I is the absolute iodine uptake by the gland (42 µg d -1 ). V I is the volume of the compartment I (7 l). In is the daily intake of stable iodine (150 µg d -1 ). Further adjustments of λ I→G were then performed to take into account the loss of iodine in feces.
Analysis demonstrates that the widely used onecompartmental presentation of the thyroid gland gives a substantial error (2 to 3 times) for the early thyroid uptake. The introduction into the model of a compartment g with 30 µg [22] of stable iodide adjusts the early thyroid uptake to values observed for euthyroidal persons. Fast exchange of iodide in the compartment g with blood acts simultaneously with processes of the thyroid hormones (THs) synthesis (compartment G). Both thyroid compartments (g and G) have the direct communication with 'iodide in blood' compartment I. It is assumed λ I→g = λ I→G ; to provide the accumulation of the 30 µg of stable iodide in the thyroid of nonpregnant persons the value λ g→I has been estimated as λ g→I = Q I λ I→g /30 µg.
Protein-bound iodine
Protein-bound iodine (PBI) in extrathyroidal tissues is represented in the model by compartment B. A volume of 25 L was adopted for B [17, 23] . For an iodine intake of 150 µg d -1 by a euthyroidal person the model predicts the content of iodine in circulating PBI in compartment B as 1,350 µg, corresponding to a concentration of 5.4 µg dl -1 , consistent with reported concentrations of 5 to 6 µg dl -1 [24] . The transfer rate from the thyroid was chosen to give hormonal iodine secretion of 50 µg d -1 [20] .
Deiodination of thyroid hormone and return to the iodide pool is represented by the transfer B to D while fecal excretion of iodine via bile is represented by B to ULI (upper large intestine). Together these transfer rates govern the concentration of hormonal iodine in plasma during pregnancy. A value of 10 µg d -1 was used for transfer to ULI [17] and the transfer from B to D was chosen in order to ensure agreement with the clinical data [24] .
Model for pregnancy
Pregnancy has been shown to be associated with increases in iodine uptake by the maternal thyroid gland and increases in concentrations of PBI in V. Berkovski maternal blood. The parameters of iodine turnover (renal and thyroidal clearance, plasma inorganic iodine concentration and absolute thyroid uptake) during the course of pregnancy have been reported elsewhere [20] . The daily stable iodine uptake by the thyroid during pregnancy was shown to vary from values similar to those in non-pregnant controls to increased values by about a factor of two (table 3) . Berghout et al. [24] determined the levels of thyroid hormones in the blood at different gestation stages (table 4) .
The structure of the model is presented in figure 2 and parameter values estimated for the euthyroid woman, under conditions of optimal intake of stable iodine (150 µg d -1 ), are given in tables 5 and 6. The behavior of iodine in the embryo and fetus is then addressed, considering the fetal hormonal cycle, bidirectional transfer and accumulation by the placenta, and iodine transfer via the amniotic fluid.
Renal clearance during pregnancy is increased from 31 to 64 ml min -1 . Based on the data of Aboul-Khair et al. [20] on renal clearance K U (τ) of iodide (table 1) the transfer rates from blood to kidneys (K) for different gestation stages were estimated using the equations described earlier. The time course of maternal thyroid clearance during pregnancy was chosen so that model predictions are consistent with the data of Aboul-Khair et al. [20] . The dynamics of 131 I in the placenta, amniotic fluid, fetal extrathyroidal tissues, and thyroid also have been studied by Aboul-Khair et al. [25] . Data are also available from other studies [26] [27] [28] [29] [30] . Radioactive iodide accumulates in the fetus before the thyroid starts functioning and is mainly concentrated in the liver and the intestine. The concentration of radioiodine in the fetal thyroid is always higher than in the mother's thyroid [25, 29] . During gestation the concentration of radioactive iodide in the fetal thyroid (FG) increases and towards the end of gestation it can exceed by 3-to 10-fold that in the maternal thyroid [31] . On the basis of human and animal data that fetal production of thyroxine (per kg body mass) during the last trimester will exceed that in the mother by 6 to 8 times [32] [33] [34] [35] , a range of 4 to 8 µg d -1 per kg body mass was assumed for the third trimester. The fetal thyroid at term was taken to have an iodine concentration of 450 µg g -1 , corresponding to 580 µg of iodine in a total mass of tissue of 1.3 g (fig. 3 ). Hormonal iodine production at term of about 6 µg per kilogram of fetal mass (3.5 kg total) was achieved by choosing a constant half-time of clearance from the gland of 20 days, i.e., a transfer rate of 0.035 d -1 . Hormonal iodine production throughout fetal development was calculated using data for the increase in fetal mass and uptake of 131 I by the fetal thyroid; values obtained were 0.7, 1.5, and 2.4 µg kg -1 fetal mass for gestational ages of 15, 20. and 25 weeks, respectively.
Iodine and circulating thyroid hormone within the fetus were modeled by compartments FI and FB, respectively. It was assumed that both compartments occupy 50% of the total fetal volume. At term, the reported concentration of PBI in the fetus of 7.2 µg dl -1 [34] corresponds to a total content of 130 µg. In determining the rate of iodine uptake by the gland, a concentration of 0.3 µg dl -1 of iodide at term in blood was assumed.
Placenta and amniotic fluid estimates of the total transfer of Ifrom maternal to fetal circulations were based on experimental observations of fetal uptake of 131 I [25] [26] [27] [28] [29] [30] 36] . Placental uptake peaks within 0.5 to 3 hours of the 131 I injection [25, 30] . Palmer and Preece [30] also reported a value of 1% for 131 I placenta uptake in guinea pigs at the third stage of gestation. To reproduce the clinically observed rapid accumulation of radioiodine in the placenta and fetus an average half-time of 0.5 hours was assumed for transfer from compartment I to P1 and from P1 to FI (fig. 2 ). The rate of the recycled flow P1 to I was set to fit the available data for short-term retention in the placenta. The transfer rate B to P2 was calculated as: λ B→P2 = K P /V B , where K P is the uteroplacental blood flow.
K P reaches the value 900 ml min -1 at term, so λ B→P2 ≈ 51 d -1 (K. Eckerman, Oak Ridge National Laboratory, Tenn., USA, personal communication, 1998). The rate of the recycled flow P2 to B was set to fit data for the longer-term retention of iodine in the placenta. Data for the mass and blood content of the placenta at dif-ferent stages [12] have been used to provide additional verification of estimated transfer rates. Tomoda [37] determined the dynamics of amniotic fluid and fetal swallowing rate in sheep; clearance rates averaged 5% h -1 and ingestion of fluid by the fetus was about 1000 ml d -1 . On the basis of these data, values λ I→A1 = 0.75 d -1 and λ A2→F1 = 0.25 d -1 were adopted. A half-time of 3 hours was assumed for transfer rate B to A2; 5.5 d -1 . Rates λ A1→I and λ A2→B were derived to fit the available data on retention of iodine in amniotic fluid. 
Model for lactation
The protection of the fetus and the embryo with respect to its iodine requirements is carried over into the immediate postnatal period with the marked excretion of iodine in the milk of the lactating mother, thereby constituting a major pathway for the elimination of iodine. In the WHO/IAEA report [38] the large statistical data about the concentration of stable iodine in breastmilk is reported. For most countries the observed values were in the range of 1 to 100 µg dl -1 . ICRP [11] gives the range of 2 to 15 µg dl -1 with an average of 7 µg dl -1 . Up to 90% of injected radioiodine can be lost by this route within 48 hours after administration. Milk to plasma iodide ratios can reach 40 and this concentration gradient can be abolished by treatment with thiocyanate, stable iodine, or perchlorate. Although a high iodine level serves to provide the newborn with an adequate iodine intake, maternal iodide stores may become depleted to a point where the mother exhibits deficiency symptoms. Enlargement of the thyroid gland has been observed in lactating women [9] .
Model parameterization
Transfer rates have been estimated in the model in the assumption of the milk/plasma concentration ratio = 35, milk clearance K milk = 0.85 l d -1 [11] , and the effective volume of mammalian glands V m = 0.42 l: λ I→Br = 35K milk / V I ≈ 4.3 d -1 , λ Br→Milk = K milk / V m ≈ 2 d -1 .
Model predictions
There is good agreement between model predictions and clinical data for fetal thyroid uptake ( fig. 4) . A 'conservative' data fit was applied at the early stages of gestation in order to prevent underestimation of radiation doses to the fetus. The model predicts fetal thyroid uptake at term of about 8%, which is in good agreement with that reported elsewhere [30] . For humans, this value corresponds to "fetal to mother concentration ratio" CF:CM ratios of about 3 to 4; Book and Goldman [39] reported such values as typical for the last trimester. Fetal age (wks) Fetal thryoid update (% intake)
